RxDoctor Payments Data

Lance Lane, PA

Physician Assistant · Belleville, ILNPI 1023088655

Payments from drug & device makers

$11,830in general payments, 2019–2025

Across 801 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Novo Nordisk$990
  • Pfizer$817
  • Teva Pharmaceuticals USA, Inc.$712
  • plus $4K from 37 others

What the payments were for

  • Food & beverage$11,791100%
  • Education$390%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,830 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$118,189
Medicare patients
292
Services billed
2,922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide83$109,496
FarxigaDapagliflozin Propanediol49$61,184
JardianceEmpagliflozin34$45,636
OzempicSemaglutide25$36,668
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$28,642
TrulicityDulaglutide22$24,622
LinzessLinaclotide21$22,101
RybelsusSemaglutide16$18,242
EliquisApixaban21$16,834
GemtesaVibegron14$14,081
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,839
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen311$6,134
Insulin Aspart FlexpenInsulin Aspart12$3,734
Albuterol Sulfate HfaAlbuterol Sulfate91$3,093
Tramadol Hcl434$3,021

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,468$134,118105 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,283$71,02364 claims
Novo NordiskOzempic, Rybelsus$990$54,91041 claims
Boehringer IngelheimJardiance$102$45,63634 claims
GSKTrelegy Ellipta$306$28,64240 claims
AbbVieLinzess$2,720$22,10121 claims
PfizerEliquis$817$16,83421 claims
Sumitomo Pharma America, Inc.Gemtesa$161$14,08114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Belleville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →